Drug Approval | July 31, 2023
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
CMOs showed an increasing reluctance to take on debt in 2022
The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
The start-up.ai team will be integrated into Verix, boosting its innovative Life Science AI capabilities
This patent-pending, high-efficiency chromatography media is used for the purification of novel peptide-based pharmaceuticals in the GLP-1 agonist class including type 2 diabetes and obesity treatments
Subscribe To Our Newsletter & Stay Updated
